Go Pro

Travere Therapeutics (TVTX) Insider Trading & Ownership

Travere Therapeutics logo
$57.36 0.00 (0.00%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$57.12 -0.24 (-0.43%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Travere Therapeutics (NASDAQ:TVTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.44%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
11
Amount Of
Insider Selling
(Last 12 Months)
$35.16M
Get TVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Travere Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TVTX Insider Buying and Selling by Quarter

Travere Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/12/2026
Roy D Baynes
Director
Sell4,500$50.00$225,000.00  
6/12/2026Sell10,000$50.07$500,700.00  
5/6/2026Sell310$43.95$13,624.50  
5/6/2026Sell2,076$43.95$91,240.20  
5/6/2026Sell22,500$43.95$988,875.00  
5/6/2026
Jula Inrig
Jula Inrig
Insider
Sell311$43.95$13,668.45  
5/6/2026Sell2,763$43.95$121,433.85  
5/5/2026Sell2,181$46.65$101,743.65  
5/5/2026Sell2,174$46.65$101,417.10  
5/5/2026
Jula Inrig
Jula Inrig
Insider
Sell2,174$46.65$101,417.10  
5/5/2026Sell2,174$46.65$101,417.10  
5/5/2026
Roy D Baynes
Director
Sell4,500$46.65$209,925.00  
5/4/2026Sell20,000$45.00$900,000.00  
5/4/2026Sell8,000$45.00$360,000.00  
5/4/2026
Jula Inrig
Jula Inrig
Insider
Sell20,000$45.00$900,000.00  
5/1/2026
Roy D Baynes
Director
Sell9,750$44.22$431,145.00  
4/22/2026Sell9,100$39.09$355,719.00  
4/15/2026Sell1,014$42.61$43,206.54  
4/15/2026Sell6,785$41.83$283,816.55  
4/15/2026Sell64,000$41.09$2,629,760.00  
4/15/2026
Jula Inrig
Jula Inrig
Insider
Sell1,018$42.61$43,376.98  
4/14/2026Sell7,248$41.93$303,908.64  
4/14/2026Sell44,715$41.21$1,842,705.15  
4/14/2026
Gary A Lyons
Gary A Lyons
Director
Sell8,000$41.07$328,560.00  
4/14/2026
Jula Inrig
Jula Inrig
Insider
Sell7,215$41.93$302,524.95  
4/14/2026Sell7,215$41.93$302,524.95  
4/14/2026
Roy D Baynes
Director
Sell32,750$41.29$1,352,247.50  
4/14/2026Sell21,977$41.07$902,595.39  
4/13/2026Sell65$28.85$1,875.25  
4/6/2026
Roy D Baynes
Director
Sell10,000$33.00$330,000.00  
4/1/2026Sell10,000$30.00$300,000.00  
4/1/2026Sell60,000$30.93$1,855,800.00  
3/16/2026Sell10,000$28.09$280,900.00  
2/4/2026Sell1,745$32.19$56,171.55  
2/4/2026Sell2,994$32.18$96,346.92  
2/4/2026
Jula Inrig
Jula Inrig
Insider
Sell1,779$32.21$57,301.59  
2/3/2026Sell7,242$32.12$232,613.04  
2/3/2026Sell7,175$32.12$230,461.00  
2/3/2026Sell100,087$32.28$3,230,808.36  
2/3/2026
Jula Inrig
Jula Inrig
Insider
Sell6,956$32.12$223,426.72  
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

2/3/2026Sell7,310$32.12$234,797.20  
2/3/2026Sell4,333$32.12$139,175.96  
2/3/2026Sell12,446$32.87$409,100.02  
1/27/2026Sell51,865$30.10$1,561,136.50  
1/23/2026Sell8,135$30.01$244,131.35  
1/20/2026Sell10,000$27.34$273,400.00  
1/6/2026
Jula Inrig
Jula Inrig
Insider
Sell445$37.75$16,798.75  
1/5/2026
Jula Inrig
Jula Inrig
Insider
Sell2,031$40.18$81,605.58  
12/24/2025
Jula Inrig
Jula Inrig
Insider
Sell15,000$42.00$630,000.00  
12/24/2025Sell4,980$40.00$199,200.00  
12/24/2025Sell7,402$40.00$296,080.00  
12/24/2025Sell60,000$40.10$2,406,000.00  
12/1/2025Sell20,000$35.01$700,200.00  
11/4/2025Sell67,115$36.00$2,416,140.00  
10/31/2025Sell5,591$35.00$195,685.00  
10/31/2025Sell18,000$35.03$630,540.00  
10/29/2025Sell27,128$30.12$817,095.36  
10/28/2025Sell92,872$30.38$2,821,451.36  
10/28/2025Sell2,662$30.00$79,860.00  
9/22/2025Sell10,000$25.00$250,000.00  
9/4/2025Sell119$19.71$2,345.49  
9/3/2025Sell454$18.20$8,262.80  
(Data available from 1/1/2013 forward)

TVTX Insider Trading Activity - Frequently Asked Questions

4.44% of Travere Therapeutics stock is owned by insiders. Learn more on TVTX's insider holdings.

The following insiders have sold TVTX shares in the last 24 months: Christopher R Cline ($1,656,554.46), Elizabeth E Reed ($4,650,286.92), Eric M Dube ($16,297,610.80), Gary A Lyons ($917,760.00), Jeffrey A Meckler ($922,400.00), Jula Inrig ($2,539,660.03), Peter Heerma ($1,257,614.76), Roy D Baynes ($3,088,317.50), Sandra Calvin ($5,674,519.61), Timothy Coughlin ($1,131,240.00), and William E Rote ($3,689,621.91).

Insiders have sold a total of 1,322,855 Travere Therapeutics shares in the last 24 months for a total of $41,825,585.99 sold.



This page (NASDAQ:TVTX) was last updated on 7/27/2026 by MarketBeat.com Staff.
From Our Partners